Skip to main contentSkip to navigation
Sirius Investors

9989.T Stock: Sundrug Co.,Ltd. Stock Price, Analysis & Insights

Get live 9989.T stock price $3841.00, comprehensive Sundrug Co.,Ltd. stock analysis, charts, news, and expert forecast. Real-time 9989.T stock data and investment insights.

3841.00
0.39%Today
9989.TSundrug Co.,Ltd. • Tokyo Stock Exchange • Healthcare
Market Cap
449.33B
Volume
601.60K
52W High
4883.00
52W Low
3526.00

Loading chart data...

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Sundrug Co.,Ltd. is a Japanese retail entity primarily focused on operating and managing drugstores and prescription-filling pharmacies throughout the country. Diversifying its retail footprint, the company also oversees a network of discount stores ...

Company Information

CEO
Hiroshi Sadakata
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
6662

Contact Information

Address
1-38-1, Wakamatsucho
Country
JP

Investment Analysis & Business Insights

Healthcare
Medical - Pharmaceuticals

Investment Highlights

Market leader with 449.3 billion market capitalization

Strong presence in the Healthcare sector with established market position

Valuation metrics suggest potential value opportunity (P/E: 14.3)

Lower volatility stock (Beta: 0.11) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Sundrug Co.,Ltd. shareholders
  • Market volatility can significantly impact stock price, especially for large-cap equities
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Sundrug Co.,Ltd.
  • Investors should consider how Sundrug Co.,Ltd. fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

449.33B

P/E Ratio (TTM)

14.31

Beta

0.11

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

43/100 ⭐⭐⭐

Overall
-1.0%
NYSE
-1.6%
NASDAQ
-0.4%
Sector1D1W1MP/EScore
Financial Services+0.3%+1.3%+1.9%19.8
83/100⭐⭐⭐⭐⭐
Technology+0.8%+1.1%+3.0%52.0
76/100⭐⭐⭐⭐⭐
Basic Materials+0.8%+0.3%+1.9%27.9
69/100⭐⭐⭐⭐
Industrials-0.3%-0.9%+2.7%43.0
64/100⭐⭐⭐⭐
Communication Services-0.8%-1.3%+0.4%21.9
48/100⭐⭐⭐
Consumer Defensive+0.6%+1.6%-2.5%31.2
44/100⭐⭐⭐
Healthcare-1.0%-2.0%+1.5%30.5
43/100⭐⭐⭐
Real Estate+0.5%-1.1%-0.0%50.0
33/100⭐⭐
Energy+0.5%-3.6%-0.0%35.9
31/100⭐⭐
Utilities+2.0%-1.3%-5.1%26.1
31/100⭐⭐
Consumer Cyclical-0.3%+0.3%-0.2%55.8
28/100⭐⭐

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-06-13.